InsidersTradesSigma
Browse the full record of transactions filed by Steineger Hilde H, Director. Director active across 2 companies, notably Strongbridge Biopharma plc. In total, 8 disclosures have been published. The latest transaction was filed on 1 October 2021 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
8 of 8 declarations
Hilde H. Steineger serves as a Board Member at Strongbridge Biopharma plc. She brings expertise in the biopharmaceutical and life sciences sectors. As a board member, Hilde plays a key role in the strategic direction of the company, ensuring regulatory compliance and innovation. Her experience is valuable in guiding strategic decisions.